Gryphon Scientific brings an unusual depth of expertise in the physical and life sciences as well as public health, economics and management disciplines. Our core strength and unique capability is science-based studies with a special focus on biological analysis.

Science Biochemistry Bioinformatics Chemistry Economics Epidemiology Health Physics Microbiology Parasitology Public Health Synthetic Biology Systems Engineering Virology

Disaster Management

Commercial Strategy

---

Science

Biochemistry

–Agent Concentration in Clinical Samples
–Developing and Curating Databases of Microbiological Data

Bioinformatics

–Evaluating Risk Reduction Measures in the Nucleic Acid Synthesis Industry
–Evaluating Oversight Mechanisms for the Gene and Oligonucleotide Industry
–Evaluating Sufficiency of Existing Regulations for Synthetic Biology
Developing and Curating Databases of Microbiological Data

Chemistry

–Chemical Incident Modeling and Gap Assessment
–Evaluating Systems for Food and Agricultural Safety and Security
–Developing and Curating Databases of Microbiological Data

Economics

–Reviewing the Nanotechnology Economy
–Chemical Incident Modeling and Gap Assessment
–Evaluating Systems for Food and Agricultural Safety and Security

Epidemiology

–Avian Influenza Laboratory Design
–Chemical Incident Modeling and Gap Assessment
–Disease Surveillance Training

Health Physics

–Chemical Incident Modeling and Gap Assessment
–Nuclear Attack Models
–Providing Technical Expertise on CBR Hazards
–End to End Analysis of Attacks with Antibiotic Resistant Biological Agents
–Efficiacy of Medical Countermeasures Against CBR Agents

Microbiology

–Establishing Requirements for Urban Biodefense Systems
–Evaluating Systems for Food and Agricultural Safety and Security
–Providing Technical Expertise on CBR Hazards
–Efficiacy of Medical Countermeasures Against CBR Agents
–Reviewing Advances in Microbiology
–Assessing the Vulnerability of the Food Supply to Attack
–Developing and Curating Databases of Microbiological Data
–Disease Surveillance Training
–Setting Requirements for Intentional Food Contamination Detection
–Geographic Spread of a Pathogen Following an Intentional Release
–End to End Analysis of Attacks with Antibiotic Resistant Biological Agents
–Agent Concentration in Clinical Samples
–Defining the Smallpox Virus
–Studies of Environmental Microbiology

Parasitology

–Developing and Curating Databases of Microbiological Data
–Setting Requirements for Intentional Food Contamination Detection

Public Health

–Avian Influenza Laboratory Design
–Disease Surveillance Training
–Evaluating a Global Disease Surveillance System
–Guiding Preparedness Policy
–Evaluating Public Health Preparedness Systems
–Resetting the Strategic Directions of a Healthcare Agency

Synthetic Biology

–Evaluating Risk Reduction Measures in the Nucleic Acid Synthesis Industry
–Evaluating Oversight Mechanisms for the Gene and Oligonucleotide Industry
–Evaluating Sufficiency of Existing Regulations for Synthetic Biology

Systems Engineering

–Establishing Requirements for Urban Biodefense Systems
–Nuclear Attack Models
–Evaluating a Global Disease Surveillance System
–Evaluating Systems for Food and Ag Safety and Security
–Evaluating Field-Deployable BioChemical Assays

Virology

–Providing Technical Expertise on CBR Hazards
–Evaluating Systems for Food and Agricultural Safety and Security
–Avian Influenza Laboratory Design
–Literature Assessment of Virus Rescue Systems
–Site-Specific Biosafety and Biosecurity Mitigation Risk Assessment
–Agent Concentration in Clinical Samples
–Evaluating Risk Reduction Measures in the Nucleic Acid Synthesis Industry
–Evaluating Oversight Mechanisms for the Gene and Oligonucleotide Industry
–Evaluating Sufficiency of Existing Regulations for Synthetic Biology
–Developing and Curating Databases of Microbiological Data
–Disease Surveillance Training
–Setting Requirements for Intentional Food Contamination Detection
–Geographic Spread of a Pathogen Following an Intentional Release
Sample CBRNE Project

Disaster Management

–Evaluating Public Health Preparedness Systems
–Chemical Incident Modeling and Gap Assessment
–Providing Technical Expertise on CBR Hazards
–End to End Analysis of Attacks with Antibiotic Resistant Biological Agents
–Catastrophic Disaster Incident Planning
–Pandemic Influenza Exercise Facilitation
–Guiding Preparedness Policy

Commercial Strategy

–Biopharmaceutical Business Development and Marketing
–Improving the Infrastructure for Neuroscience Research
–Resetting the Strategic Directions of a Healthcare Agency
–Grant Acquisition and Administrative Support